HomeAbout UsNewsFujifilm announces the start of a phase II clinical trial of its influenza antiviral drug “Avigan® Tablet” for COVID-19 patients in the U.S.

Fujifilm announces the start of a phase II clinical trial of its influenza antiviral drug “Avigan® Tablet” for COVID-19 patients in the U.S.

2020-04-09

FUJIFILM Corporation announces the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan® Tablet” for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus.